Social media

CRAs are no longer just monitors, they’re strategic site partners. Discover how tech is driving this shift in this ACT article featuring ICON’s Helen Yeardley. https://ow.ly/3qob50XB6Vo

CRAs are no longer just monitors, they’re strategic site partners. Discover how tech is driving this shift in this ACT article featuring ICON’s Helen Yeardley. https://ow.ly/3NOG50XB6Vn

ICON Concierge Services delivers on reducing burden while maintaining data quality. In a hybrid VMS study with 1,000 participants, our Concierge Services provided support to patients and sites, enabling a digital health ...

ICON Concierge Services delivers on reducing burden while maintaining data quality. In a hybrid VMS study with 1,000 participants, our Concierge Services provided support to patients and sites, enabling a digital health ...

One of the most valuable Journals & Congresses features is Watchlists. The system will send you updates on your priority list whenever updated information is available. Deadline changes, location confirmation, detail upd...

One of the most valuable Journals & Congresses features is Watchlists. The system will send you updates on your priority list whenever updated information is available. Deadline changes, location confirmation, detail upd...

Analysts, rejoice. Metys® offers predefined dashboards for quick answers and a powerful report builder for custom views – plus Excel integration for seamless workflows. It’s market intelligence, your way. Explore Mety...

Analysts, rejoice. Metys® offers predefined dashboards for quick answers and a powerful report builder for custom views – plus Excel integration for seamless workflows. It’s market intelligence, your way. Explore Mety...

Although advances in antiretroviral therapies are helping to curtail the HIV epidemic, there are limitations introduced by access and adherence. Find out what developers need to know when navigating these obstacles in th...

In settings with global HIV treatment disparities, the long-term success of antiretroviral interventions is jeopardised. Discover considerations for developing therapies that overcome obstacles in access, adherence and...

How to navigate EU MAA Regulations and Registration. Regulatory legislation in China differs substantially from that of the European Union. For Chinese biotech companies looking to enter the market it is critical to as...

How to navigate EU MAA Regulations and Registration For Chinese pharma and biotech companies looking to expand into the European Union’s market of over 450 million people, the first step is to understand the significant...